Hologic, Inc.'s (HOLX) sustained momentum in the Molecular Diagnostics portfolio is poised to fuel its growth in the upcoming quarters. A crucial part of its long-term strategy, the company is planning to expand into more countries overseas, which are largely untapped. It is also using its strong cash position strategically by focusing on acquisitions and share buybacks. Meanwhile, concerns remain over the impact of macroeconomic challenges on Hologic's operations. Adverse currency impact also adds to the w ...